Anti-AGER antibody (133-182 aa) (STJ95358)

SKU:
STJ95358
£48.00 - £252.00
Processing The item has been added

Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Rabbit polyclonal antibody anti-Advanced glycosylation end product-specific receptor (133-182 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality : Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:20000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: AGER
Gene ID: 177
Uniprot ID: RAGE_HUMAN
Immunogen Region: 133-182 aa
Specificity: RAGE Polyclonal Antibody detects endogenous levels of RAGE protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human RAGE at the amino acid range 133-182
Post Translational Modifications Phosphorylated on its cytoplasmic domain by PKCzeta/PRKCZ upon ligand binding. Phosphorylated by ATM following DNA damage. Targeted by the ubiquitin E3 ligase subunit FBXO10 to mediate its ubiquitination and degradation.
Function Cell surface pattern recognition receptor that senses endogenous stress signals with a broad ligand repertoire including advanced glycation end products, S100 proteins, high-mobility group box 1 protein/HMGB1, amyloid beta/APP oligomers, nucleic acids, histones, phospholipids and glycosaminoglycans. Advanced glycosylation end products are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. These ligands accumulate at inflammatory sites during the pathogenesis of various diseases including diabetes, vascular complications, neurodegenerative disorders and cancers, and RAGE transduces their binding into pro-inflammatory responses. Upon ligand binding, uses TIRAP and MYD88 as adapters to transduce the signal ultimately leading to the induction of inflammatory cytokines IL6, IL8 and TNFalpha through activation of NF-kappa-B. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key pro-inflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space. Participates in endothelial albumin transcytosis together with HMGB1 through the RAGE/SRC/Caveolin-1 pathway, leading to endothelial hyperpermeability. Mediates the loading of HMGB1 in extracellular vesicles (EVs) that shuttle HMGB1 to hepatocytes by transferrin-mediated endocytosis and subsequently promote hepatocyte pyroptosis by activating the NLRP3 inflammasome. Binds to DNA and promotes extracellular hypomethylated DNA (CpG DNA) uptake by cells via the endosomal route to activate inflammatory responses. Mediates phagocytosis by non-professional phagocytes (NPP) and this is enhanced by binding to ligands including RNA, DNA, HMGB1 and histones. Promotes NPP-mediated phagocytosis of Saccharomyces cerevisiae spores by binding to RNA attached to the spore wall. Also promotes NPP-mediated phagocytosis of apoptotic cells. Following DNA damage, recruited to DNA double-strand break sites where it colocalizes with the MRN repair complex via interaction with double-strand break repair protein MRE11. Enhances the endonuclease activity of MRE11, promoting the end resection of damaged DNA. Promotes DNA damage repair in trophoblasts which enhances trophoblast invasion and contributes to placental development and maintenance. Protects cells from DNA replication stress by localizing to damaged replication forks where it stabilizes the MCM2-7 complex and promotes faithful progression of the replication fork. Mediates the production of reactive oxygen species (ROS) in human endothelial cells.
Protein Name Advanced Glycosylation End Product-Specific Receptor
Receptor For Advanced Glycosylation End Products
Database Links Reactome: R-HSA-445989
Reactome: R-HSA-879415
Reactome: R-HSA-933542
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Cell Projection
Phagocytic Cup
Early Endosome
Nucleus
Detected On The Surface Of Cd11c+ Peripheral Blood Mononuclear Cells Under Basal Conditions And After Activation
No Surface Expression Is Observed On Resting T Cells
Localizes Intracellularly In Early Endosomes In Activated T Cells Of Healthy Controls And In Resting T Cells Of Patients With Type I Diabetes
Nuclear Translocation Is Enhanced By Irradiation
Hypoxia And Reperfusion Injury To Brain Or Kidney
Nuclear Localization Is Enhanced By Dna Damage In Trophoblasts And Increases In Pre-Term Labor And Preeclampsia Placentas Compared To Control Placentas
Isoform 1: Cell Membrane
Isoform 2: Secreted
Isoform 10: Cell Membrane
Alternative Antibody Names Anti-Advanced Glycosylation End Product-Specific Receptor antibody
Anti-Receptor For Advanced Glycosylation End Products antibody
Anti-AGER antibody
Anti-RAGE antibody

Information sourced from Uniprot.org